Chronic obstructive pulmonary disease (COPD) remains a leading cause of morbidity and mortality worldwide, making it essential for clinicians to stay aligned with the latest evidence-based recommendations. The GOLD 2026 Report introduces important updates that can influence diagnosis, pharmacological treatment, exacerbation prevention, and long-term disease management.

In this session, Dr Deepti Badwe will review the key recommendations from the GOLD 2026 update and discuss how they translate into everyday clinical practice. The session will cover patient assessment, individualized inhaled therapy, management of exacerbations, non-pharmacological interventions, and strategies to optimize long-term outcomes. Designed with a practical focus, the discussion will help clinicians identify what has changed, what remains the same, and how to incorporate the latest guidance into routine COPD care.